Literature DB >> 35246611

Pigment epithelium-derived factor, an anti-VEGF factor, delays ovarian cancer progression by alleviating polarization of tumor-associated macrophages.

Rui Ma1, Xiaolin Chu1, Yiting Jiang1, Qing Xu2.   

Abstract

Ovarian cancer (OC) is one of the most dangerous gynecological malignancies with no effective treatment so far. Pigment epithelium-derived factor (PEDF) has been reported to have ideal anti-tumor effects, but its relationship with the regulation of tumor-associated macrophage polarization is currently unclear. In this study, the mRNA expression of PEDF and macrophage markers were determined in OC tissues from clinic patients and five OC (A2780, SKOV3, CAOV3, OVCAR3, and OVCA433) cell lines through quantitative reverse transcription PCR. Afterwards, tumor growth, cell proliferation and apoptosis, and macrophage polarization in OC tumor-bearing mice with PEDF overexpression were recorded and investigated. Finally, the polarization of macrophages was explored in the presence of lentiviral PEDF overexpression, adipose triglyceride lipase (ATGL) and laminin receptor (LR) knockdown, and mitogen-activated protein kinase (MAPK) pathway inhibition. Our results suggest that PEDF mRNA level is significantly decreased in OC tissues and cells and has a significant negative correlation with OC progression and the level of tumor-related macrophage markers. Furthermore, OC tumors overexpressing PEDF show suppressed growth viability and increased apoptosis rate. The fluorescence activated cell sorting (FACS) analysis reveals that PEDF can promote macrophage polarization in OC tumors towards M1 subtype. Mechanistically, we found that ATGL and extracellular-regulated kinase 1/2 (ERK1/2) signaling are involved in the regulation of macrophage polarization in OC tumors by PEDF. Taken together, these data indicate that the role of PEDF in regulating the polarization of tumor-associated macrophages may make it a potential therapeutic strategy for the treatment of OC in the future.
© 2022. The Author(s), under exclusive licence to Springer Nature America, Inc.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35246611     DOI: 10.1038/s41417-022-00447-4

Source DB:  PubMed          Journal:  Cancer Gene Ther        ISSN: 0929-1903            Impact factor:   5.854


  40 in total

Review 1.  Macrophage diversity enhances tumor progression and metastasis.

Authors:  Bin-Zhi Qian; Jeffrey W Pollard
Journal:  Cell       Date:  2010-04-02       Impact factor: 41.582

Review 2.  Macrophage plasticity and polarization in tissue repair and remodelling.

Authors:  Alberto Mantovani; Subhra K Biswas; Maria Rosaria Galdiero; Antonio Sica; Massimo Locati
Journal:  J Pathol       Date:  2012-11-29       Impact factor: 7.996

3.  Clinical Use of Programmed Cell Death-1 and Its Ligand Expression as Discriminatory and Predictive Markers in Ovarian Cancer.

Authors:  Jayanta Chatterjee; Wei Dai; Nor Haslinda Abd Aziz; Pei Yun Teo; John Wahba; David L Phelps; Christian J Maine; Lynsey M Whilding; Roberto Dina; Giorgia Trevisan; Kirsty J Flower; Andrew J T George; Sadaf Ghaem-Maghami
Journal:  Clin Cancer Res       Date:  2016-12-16       Impact factor: 12.531

Review 4.  Macrophages, innate immunity and cancer: balance, tolerance, and diversity.

Authors:  Alberto Mantovani; Antonio Sica
Journal:  Curr Opin Immunol       Date:  2010-02-09       Impact factor: 7.486

Review 5.  Mononuclear phagocyte heterogeneity in cancer: different subsets and activation states reaching out at the tumor site.

Authors:  Damya Laoui; Eva Van Overmeire; Kiavash Movahedi; Jan Van den Bossche; Elio Schouppe; Camille Mommer; Alexandros Nikolaou; Yannick Morias; Patrick De Baetselier; Jo A Van Ginderachter
Journal:  Immunobiology       Date:  2011-06-30       Impact factor: 3.144

Review 6.  Alternative activation of macrophages: mechanism and functions.

Authors:  Siamon Gordon; Fernando O Martinez
Journal:  Immunity       Date:  2010-05-28       Impact factor: 31.745

Review 7.  The immune system in the pathogenesis of ovarian cancer.

Authors:  Bridget Charbonneau; Ellen L Goode; Kimberly R Kalli; Keith L Knutson; Melissa S Derycke
Journal:  Crit Rev Immunol       Date:  2013       Impact factor: 2.214

8.  Prognostic significance of tumor-associated macrophages in solid tumor: a meta-analysis of the literature.

Authors:  Qiong-wen Zhang; Lei Liu; Chang-yang Gong; Hua-shan Shi; Yun-hui Zeng; Xiao-ze Wang; Yu-wei Zhao; Yu-quan Wei
Journal:  PLoS One       Date:  2012-12-28       Impact factor: 3.240

Review 9.  Current Ovarian Cancer Maintenance Strategies and Promising New Developments.

Authors:  Vinaya Gogineni; Susan Morand; Hannah Staats; Rachel Royfman; Monika Devanaboyina; Katelyn Einloth; Danielle Dever; Laura Stanbery; Phylicia Aaron; Luisa Manning; Adam Walter; Gerald Edelman; Lance Dworkin; John Nemunaitis
Journal:  J Cancer       Date:  2021-01-01       Impact factor: 4.207

Review 10.  The role of tumour-associated macrophages in tumour progression: implications for new anticancer therapies.

Authors:  L Bingle; N J Brown; Claire E Lewis
Journal:  J Pathol       Date:  2002-03       Impact factor: 7.996

View more
  1 in total

Review 1.  Recent Advances on the Role of ATGL in Cancer.

Authors:  Renshuai Zhang; Jingsen Meng; Shanbo Yang; Wenjing Liu; Lingyu Shi; Jun Zeng; Jing Chang; Bing Liang; Ning Liu; Dongming Xing
Journal:  Front Oncol       Date:  2022-07-13       Impact factor: 5.738

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.